Exclusive special offer and discount title banner vector image

GLOBAL BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Global Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) by Geography


MARKET OVERVIEW

The global biopsy devices market was valued at $xx million in 2023 and is expected to reach $xx million by 2032, growing at a CAGR of 7.23% during the forecast period 2024-2032

Biopsy devices are specialized tools used in medicine to extract tissue samples from the body for diagnostic purposes. These devices are employed to obtain tissue specimens from various organs or areas of concern, aiding in the identification of abnormalities, diseases, or the nature of a medical condition. They are important in the diagnostic process, allowing healthcare professionals to examine the cellular structure and characteristics of tissues to determine the presence of cancer, infections, inflammations, or other abnormalities.

Biopsy devices work by enabling precise and minimally invasive tissue sampling. They are guided by imaging techniques such as ultrasound, MRI, CT scans, or endoscopy to accurately target the area for biopsy. Once the tissue sample is obtained, it undergoes laboratory analysis, where pathologists examine it under a microscope to provide a diagnosis.

Biopsy Devices Market

Read our latest blog on the Biopsy Devices Market

GROWTH ENABLERS

Key growth enablers of the global biopsy devices market:

  • Rising prevalence of cancer
    • As per the World Health Organization (WHO), cancer stands as a prominent contributor to global mortality, causing approximately 10 million deaths in 2020, representing nearly one out of every six recorded deaths. Among the most prevalent forms of cancer are breast, lung, colon, rectal, and prostate cancers.
    • As cancer rates continue to rise, there’s a growing need for accurate and early diagnostic methods. These devices are integral in the sphere by enabling healthcare professionals to obtain tissue samples for precise diagnosis and staging of cancers.
    • With rising awareness about the importance of early detection and personalized treatment strategies, the demand for biopsy devices has surged. They facilitate minimally invasive procedures, aiding in the identification and characterization of various cancers, including breast, lung, colon, rectal, and prostate cancers
  • Increasing demand for minimally invasive surgeries
  • Surge in the number of hospitals and diagnostics centers

GROWTH RESTRAINTS

Key growth restraining factors of the global biopsy devices market:

  • High risk of infection for patients
    • Biopsy procedures, particularly invasive ones, carry a risk of introducing infections at the site of tissue sampling. Despite stringent sterilization protocols and safety measures, there remains a concern for potential complications post-biopsy, including infections.
    • The potential for infections sets a significant concern for both patients and healthcare providers, impacting the confidence in using biopsy devices, especially in invasive procedures.
    • Addressing this challenge requires continuous improvements in infection control protocols, advancements in device designs to minimize tissue trauma and contamination, and stringent adherence to best practices in sterile procedures. Mitigating the risk of infection is important to maintain trust in the safety and reliability of biopsy devices, ensuring their continued acceptance and utilization in clinical settings.
  • High cost of biopsy procedures
  • Lack of skilled professionals

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Biopsy Devices Market | Top Market Trends

  • As per the Centers for Medicare & Medicaid Services (CMS), healthcare expenditure in the United States experienced a 4.1 % growth in 2022, totaling $4.5 trillion, equating to $13,493 per individual. With healthcare costs on the rise, there’s an increased focus on efficient diagnostic tools like biopsy devices that aid in accurate disease identification and treatment planning. The growing investment in healthcare services and technologies signifies an opportunity for the biopsy devices market to provide to the escalating demands for advanced diagnostic solutions amid the expanding healthcare domain.
  • As healthcare paradigms shift towards proactive wellness strategies and early disease detection, biopsy devices are important in supporting this shift. With an increasing focus on preventive medicine, there’s a heightened emphasis on early and accurate diagnosis, enabling timely intervention and treatment. Biopsy devices contribute substantively to preventive healthcare by facilitating the early detection of various conditions, including cancer and other diseases. These devices enable healthcare practitioners to obtain tissue samples for thorough analysis, aiding in the identification of abnormalities or potential health risks before they progress to more advanced stages.

MARKET SEGMENTATION

Market Segmentation – Product, Application, and End Use –

Market by Product: 

  • Needle-Based Biopsy Guns
    • Vacuum-Assisted Biopsy (VAB) Devices
    • Fine Needle Aspiration Biopsy (FNAB) Devices
    • Core Needle Biopsy (CNB) Devices
    • Needle-based procedures offer minimally invasive techniques for obtaining tissue samples, resulting in reduced patient discomfort, shorter recovery times, and lower risk of complications compared to more invasive biopsy methods. This aspect significantly contributes to their widespread acceptance among both patients and healthcare providers.
    • Moreover, needle-based biopsy devices assist in a wide range of applications, allowing sampling from various organs and tissues, including breast, lung, prostate, and others. The versatility of these devices makes them indispensable tools across different medical specialties, from oncology to interventional radiology and beyond.
    • Additionally, advancements in needle-based biopsy technologies have led to improved precision and accuracy, enhancing diagnostic capabilities. The development of imaging-guided biopsy procedures further enhances the accuracy of tissue sampling, ensuring targeted and precise biopsies.
  • Biopsy Forceps
  • Other Products

Market by Application:

  • Oncology
    • Biopsy devices enable oncologists to obtain tissue samples from tumors or suspicious lesions. These samples are crucial for accurate diagnosis, identifying the specific type of cancer, its grade, stage, and the presence of specific genetic mutations or biomarkers.
    • Oncologists use biopsies to assess the response of tumors to treatments. This allows for modifications in the treatment regimen if the cancer shows resistance or if there’s a need for alternative therapies.
    • Biopsies help in customized treatment plans for cancer patients. They provide critical information to determine the most effective treatment options, such as chemotherapy, radiation therapy, targeted therapies, or immunotherapy, based on the molecular characteristics of the tumor.
  • Gastroenterology
  • Pulmonology
  • Dermatology
  • Other Applications

Market by End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions: 
    • The upsurge in cancer cases substantively impacts and fosters the biopsy devices market in North America. As projected by the American Cancer Society, it was estimated that in 2022, there would be approximately 1.9 million new cases of cancer diagnosed, alongside an anticipated 609,360 cancer-related deaths in the United States. 
    • The escalating expenditure on healthcare infrastructure in North America serves as a driving force propelling the biopsy devices market. As the healthcare field continues to expand and invest in advanced infrastructure, there’s a significant emphasis on enhancing diagnostic capabilities. The rising healthcare expenditure contributes to the adoption of innovative technologies, including biopsy devices, aimed at improving disease detection and patient outcomes.
  • EuropeThe United Kingdom, France, Germany, Spain, Italy, Belgium, Poland, Denmark, and Rest of Europe
  • Asia-PacificChina, Japan, India, South Korea, Taiwan, Singapore, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Major players in the global biopsy devices market:

  • Cardinal Health
  • Hologic Inc
  • Danaher Corporation
  • CONMED Corporation
  • Cook Medical 

Key strategies adopted by some of these companies:

  • Argon Medical Devices, in March 2023, unveiled the SuperCore Advantage semi-automatic biopsy instrument, marking the most recent inclusion in the firm’s portfolio of soft tissue biopsy products available in the United States.
  • Mammotome unveiled the introduction of the Mammotome DualCore™ Dual Stage Core Biopsy System in August 2022.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedProduct, Application, and End Use
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, CONMED Corporation, Cook Medical, DTR Medical, Medtronic Plc, INRAD Inc, Boston Scientific, Becton Dickinson and Company, Mammotome, Argon Medical Devices
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    5. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE- BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA BIOPSY DEVICES MARKET DRIVERS
      3. NORTH AMERICA BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN NORTH AMERICA BIOPSY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE BIOPSY DEVICES MARKET DRIVERS
      3. EUROPE BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN EUROPE BIOPSY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. UNITED KINGDOM
        2. GERMANY
        3. FRANCE
        4. ITALY
        5. SPAIN
        6. POLAND
        7. BELGIUM
        8. DENMARK
        9. REST OF EUROPE
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC BIOPSY DEVICES MARKET DRIVERS
      3. ASIA-PACIFIC BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN ASIA-PACIFIC BIOPSY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. SOUTH KOREA
        5. TAIWAN
        6. SINGAPORE
        7. AUSTRALIA & NEW ZEALAND
        8. REST OF ASIA-PACIFIC
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD BIOPSY DEVICES MARKET DRIVERS
      3. REST OF WORLD BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN REST OF WORLD BIOPSY DEVICES MARKET
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
        2. MIDDLE EAST & AFRICA
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. COOK MEDICAL
      6. DTR MEDICAL
      7. INRAD INC
      8. BOSTON SCIENTIFIC
      9. MEDTRONIC PLC
      10. BECTON DICKINSON AND COMPANY
      11. MAMMOTOME
      12. ARGON MEDICAL DEVICES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GLOBAL NEEDLE-BASED BIOPSY GUNS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL NEEDLE-BASED BIOPSY GUNS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GLOBAL VACUUM-ASSISTED BIOPSY (VAB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL VACUUM-ASSISTED BIOPSY (VAB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GLOBAL CORE NEEDLE BIOPSY (CNB) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL CORE NEEDLE BIOPSY (CNB) DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GLOBAL BIOPSY GUIDANCE SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL BIOPSY GUIDANCE SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GLOBAL BIOPSY NEEDLES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL BIOPSY NEEDLES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: GLOBAL BIOPSY FORCEPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL BIOPSY FORCEPS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 20: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 22: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 24: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 26: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 28: GLOBAL PULMONOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL PULMONOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 30: GLOBAL DERMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL DERMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 32: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 34: GLOBAL BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 38: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 40: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 42: GLOBAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL BIOPSY DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 44: NORTH AMERICA BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: NORTH AMERICA BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 46: KEY PLAYERS OPERATING IN NORTH AMERICA BIOPSY DEVICES MARKET

TABLE 47: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 48: EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 49: KEY PLAYERS OPERATING IN EUROPE BIOPSY DEVICES MARKET

TABLE 50: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 51: ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 52: KEY PLAYERS OPERATING IN ASIA-PACIFIC BIOPSY DEVICES MARKET

TABLE 53: REST OF WORLD BIOPSY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 54: REST OF WORLD BIOPSY DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 55: KEY PLAYERS OPERATING IN REST OF WORLD BIOPSY DEVICES MARKET

TABLE 56: LIST OF MERGERS & ACQUISITIONS

TABLE 57: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 58: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 59: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING 

FIGURE 4: MARKET MATURITY ANALYSIS

FIGURE 5: MARKET CONCENTRATION ANALYSIS

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 8: GLOBAL BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 9: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 10: GLOBAL BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 11: GLOBAL BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 12: GLOBAL BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 13: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 14: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 15: GLOBAL BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 16: GLOBAL BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 17: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 18: GLOBAL BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: GLOBAL BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 20: GLOBAL BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 21: GLOBAL BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 22: GLOBAL BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 23: GLOBAL BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023

FIGURE 24: GLOBAL BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 25: GLOBAL BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 26: GLOBAL BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 27: NORTH AMERICA BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 28: UNITED STATES BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 29: CANADA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 30: EUROPE BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 31: UNITED KINGDOM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 32: GERMANY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 33: FRANCE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 34: ITALY BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 35: SPAIN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 36: POLAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 37: BELGIUM BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 38: DENMARK BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 39: REST OF EUROPE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 41: CHINA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 42: JAPAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 43: INDIA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 44: SOUTH KOREA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 45: TAIWAN BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 46: SINGAPORE BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 48: REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 49: REST OF WORLD BIOPSY DEVICES MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 50: LATIN AMERICA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 51: MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FAQ’s

FAQs

The accuracy of biopsy results depends on multiple factors, including the technique used, the skill of the healthcare professional performing the procedure, and the pathologist’s expertise in analyzing the tissue samples. Generally, biopsy results are highly accurate and crucial for determining appropriate treatment plans.

The time taken for biopsy results varies depending on the type of biopsy, the laboratory workload, and the urgency of the case. Some results may be available within a few days, while others might take longer.